Afya Limited (NASDAQ:AFYA) Short Interest Update

Afya Limited (NASDAQ:AFYA) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 361,326 shares, a growth of 32.4% from the December 15th total of 272,979 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 105,049 shares, the short-interest ratio is currently 3.4 days. Based on an average daily volume of 105,049 shares, the short-interest ratio is currently 3.4 days. Approximately 0.4% of the shares of the company are sold short.

Afya Price Performance

NASDAQ:AFYA opened at $13.93 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $1.31 billion, a P/E ratio of 10.02, a P/E/G ratio of 0.52 and a beta of 0.53. Afya has a 12 month low of $13.12 and a 12 month high of $19.90. The business’s 50-day moving average is $14.78 and its 200 day moving average is $14.97.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research report on Wednesday, October 8th. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reiterated a “neutral” rating and issued a $16.00 price target (down from $18.00) on shares of Afya in a research report on Friday. Wall Street Zen upgraded shares of Afya from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 10th. Finally, Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Afya presently has an average rating of “Hold” and a consensus target price of $17.38.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AFYA. Goldman Sachs Group Inc. increased its position in Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after purchasing an additional 28,226 shares during the last quarter. Perpetual Ltd grew its stake in shares of Afya by 1.8% in the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after buying an additional 2,730 shares in the last quarter. R Squared Ltd bought a new stake in shares of Afya in the 2nd quarter worth about $264,000. Carrera Capital Advisors purchased a new stake in shares of Afya during the 2nd quarter valued at about $1,750,000. Finally, Campbell & CO Investment Adviser LLC raised its position in shares of Afya by 31.5% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock valued at $917,000 after buying an additional 12,286 shares in the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.